Home › Pamela J. Craig and Dr. Paul B. Rothman Elected to Merck Board of Directors
 

Keywords :   


Pamela J. Craig and Dr. Paul B. Rothman Elected to Merck Board of Directors

2015-07-28 22:15:00| Merck.com - Corporate News

Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that Pamela J. Craig, retired chief financial officer of Accenture, and Dr. Paul B. Rothman, dean of the medical faculty, vice president for medicine of The Johns Hopkins University and chief executive officer of Johns Hopkins Medicine, will join the companys board of directors, effective Sept. 1, 2015. Language: English Contact: MerckMedia Contacts:Lainie Keller, 908-236-5036orInvestor Contacts:Justin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: of board paul directors

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
26.06Eastern North Pacific Tropical Weather Outlook
26.06Atlantic Tropical Weather Outlook
26.06Aer Lingus pilots begin industrial action over pay dispute
25.06Water requirements in the summer
25.06New model Is transforming the study of liver abscesses in cattle
25.06Royal Mail buyer to make offer for all staff shares
25.06World's biggest music labels sue over AI copyright
25.06Hybrid Software wins FLAG Vendor Partner of the Year award
More »